Regulating Cannabis
Download Regulating Cannabis full books in PDF, epub, and Kindle. Read online free Regulating Cannabis ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Toby Seddon |
| Publisher | : Palgrave Macmillan |
| Total Pages | : 132 |
| Release | : 2020-09-04 |
| Genre | : Social Science |
| ISBN | : 9783030529260 |
This book explores one of the most pressing public policy questions for the 2020s: how should we regulate cannabis? The global cannabis prohibition regime is fragmenting as more countries experiment with decriminalization and legalization, and this book aims to make sense of this rapidly changing world. The ‘cannabis challenge’ is complex. How do we balance creating a potentially lucrative legal cannabis industry with protecting public health? How do we hardwire social and racial justice into our reform initiatives? How do we build a cannabis trade that is environmentally sustainable? The book seeks to make sense of our present through a state-of-the-art global review of cannabis law reform initiatives – mapping what has been done, where, and with what impacts. It attempts to generate new ideas for the future of cannabis regulation by viewing it through the lens of business regulation and learning lessons from how other consumer products are regulated.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 487 |
| Release | : 2017-03-31 |
| Genre | : Science |
| ISBN | : 0309453070 |
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.
| Author | : Tom Decorte |
| Publisher | : Archway Publishing |
| Total Pages | : 93 |
| Release | : 2018-04-30 |
| Genre | : Political Science |
| ISBN | : 1480861448 |
With the legalization of recreational cannabis markets in Uruguay, Canada, and several U.S. states, a breakthrough in conventional cannabis policy is emerging. But legalization is not a binary choice between prohibition and some regulated commercial model (like alcohol). A commercial market is just one of many ways to implement legalizationand moving directly from prohibition to commercial legalization leaps from one extreme to the other. Tom Decorte, a criminologist and anthropologist at Ghent University (Belgium), who has published numerous articles on substance use, cannabis markets, and local drug monitoring systems, argues that most of us are bypassing other, safer forms of legalization, including the nonprofit model. He explores topics such as: Why we need to consider regulation of cannabis markets. How local authorities and grassroots movements are advocating change. How to best design and implement approaches to legalization. Join the author as he examines international regulatory controls over cannabis possession, use, and cultivationas well as a framework for regulating the cannabis market via a nonprofit corporate model that promotes public health and safety over profits
| Author | : David Jernigan |
| Publisher | : |
| Total Pages | : |
| Release | : 2021 |
| Genre | : Cannabis |
| ISBN | : 9780875533179 |
"This book does not take a position on whether expanded legal use of non-medical cannabis should continue. It seeks to provide a consolidated source for the evidence, issues, challenges, and experiences with legalized cannabis for non-medical use and the lessons learned from America's long history with alcohol and tobacco control. It seeks to provide guidance for those who are and will continue to be in positions to struggle with the issue of cannabis control"--
| Author | : British Medical Association |
| Publisher | : CRC Press |
| Total Pages | : 160 |
| Release | : 2020-08-17 |
| Genre | : Medical |
| ISBN | : 1000159655 |
At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.
| Author | : Brian F. Thomas |
| Publisher | : Elsevier |
| Total Pages | : 133 |
| Release | : 2015-12-01 |
| Genre | : Science |
| ISBN | : 0128046708 |
A volume in the Emerging Issues in Analytical Chemistry series, The Analytical Chemistry of Cannabis: Quality Assessment, Assurance, and Regulation of Medicinal Marijuana and Cannabinoid Preparations provides analytical chemistry methods that address the latest issues surrounding cannabis-based products. The plethora of marketed strains of cannabis and cannabinoid-containing products, combined with the lack of industry standards and labelling requirements, adds to the general perception of poor quality control and limited product oversight. The methods described in this leading-edge volume help to support the manufacturing, labelling, and distribution of safe and consistent products with known chemical content and demonstrated performance characteristics. It treats analytical chemistry within the context of the diverse issues surrounding medicinal and recreational cannabis in a manner designed to foster understanding and rational perspective in non-scientist stakeholders as well as scientists who are concerned with bringing a necessary degree of order to a field now characterized by confusion and contradiction. - Addresses current and emerging analytical chemistry methods - an approach that is unique among the literature on this topic - Presents information from a broad perspective of the issues in a single compact volume - Employs language comprehensible to non-technical stakeholders as well as to specialists in analytical chemistry
| Author | : National Research Council (U.S.). Committee on Substance Abuse and Habitual Behavior |
| Publisher | : National Academies Press |
| Total Pages | : 55 |
| Release | : 1982-01-01 |
| Genre | : Drug abuse |
| ISBN | : |
Defenders of marijuana use may seize on the ambiguity or absence of evidence for such damage and ignore any other effects on education or safety; those opposed to marijuana use may emphasize the possibility of chronic disease that is suggested by some laboratory findings and ignore the social, political, and economic costs of fighting a well-established custom. The Committee wishes to make clear what it regards as the limits of this report for the selection of policy alteratives. Scientific judgment can estimate the prevalence of different kinds of use, risks to health, economic costs, and the like under current policies and can try to project such estimates for new policies. It can come to some conclusions based on those estimates. But selection of an alternative is always a value-governed choice, which can ultimately be made only by the political process.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 216 |
| Release | : 2000-12-30 |
| Genre | : Medical |
| ISBN | : 0309065313 |
Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.
| Author | : Barak S. Cohen |
| Publisher | : ABA Publishing American Bar Association |
| Total Pages | : |
| Release | : 2021 |
| Genre | : Cannabis |
| ISBN | : 9781641058261 |
"This book will offer initial guidance to dedicated practitioners, both in-house and from outside law firms, who provide legal services to cannabis businesses or to businesses that are considering entering the cannabis industry"--
| Author | : Tom Decorte |
| Publisher | : Routledge |
| Total Pages | : 459 |
| Release | : 2020-02-20 |
| Genre | : Social Science |
| ISBN | : 0429765045 |
Marijuana is the most widely used illegal drug in the world. Over the past couple of decades, several Western jurisdictions have seen reforms in, or changes to, the way cannabis use is being controlled, departing from traditional approaches of criminal prohibition that have dominated cannabis use control regimes for most of the twentieth century. While reform is stalled at the international level, the last decade has seen an acceleration of legislative and regulatory reforms at the local and national levels, with countries no longer willing to bear the human and financial costs of prohibitive policies. Furthermore, legalization models have been implemented in US states, Canada and Uruguay, and are being debated in a number of other countries. These models are providing the world with unique pilot programs from which to study and learn. This book assembles an international who’s who of cannabis scholars who bring together the best available evidence and expertise to address questions such as: How should we evaluate the models of cannabis legalization as they have been implemented in several jurisdictions in the past few years? Which scenarios for future cannabis legalization have been developed elsewhere, and how similar/different are they from the models already implemented? What lessons from the successes and failures experienced with the regulation of other psychoactive substances (such as alcohol, tobacco, pharmaceuticals and “legal highs”) can be translated to the effective regulation of cannabis markets? Legalizing Cannabis will appeal to anyone interested in public health policies and drug policy reform and offers relevant insights for stakeholders in any other country where academic, societal or political evaluations of current cannabis policies (and even broader: current drug policies) are a subject of debate.
